Biotech · Private company
Salubris Biotherapeutics Inc
Track this companyFree. Adds Salubris Biotherapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- JK07Phase 2 · Heart Failure With Reduced Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- JK07Phase 2 · HFrEF - Heart Failure With Reduced Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
- JK07Phase 1 · Heart Failure With Preserved Ejection FractionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary HypertensionPHASE2 · WITHDRAWN · started Dec 15, 2025ClinicalTrials.gov NCT07221513 · fetched Nov 12, 2026
- Study of JK07 in Patients With Chronic Heart FailurePHASE2 · ACTIVE_NOT_RECRUITING · started Mar 28, 2024ClinicalTrials.gov NCT06369298 · fetched Nov 12, 2026
- Single-Ascending Dose Study of JK07 in Subjects With HFpEFPHASE1 · WITHDRAWN · started Oct 21, 2022ClinicalTrials.gov NCT05322616 · fetched Nov 12, 2026
- Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)PHASE1 · COMPLETED · started Sep 21, 2020ClinicalTrials.gov NCT04210375 · fetched Nov 12, 2026